产品编号：T795157
产品规格：1mg
产品价格：面议
| 标准品编号: | T795157 |
| 名称: | 3α,7α,12α-Trihydroxycoprostanic Acid-d3 |
| 别名: | (3α,5β,7α,12α)-3,7,12-Trihydroxy-cholestan-26-oic-27,27,27-d3 Acid; (3α,5β,7α,12α)-3,7,12-Trihydroxycholestan-26-oic Acid-d3; 3α,7α,12α-Trihydroxy-5β-cholestan-26-oic Acid-d3; 3α,7α,12α-Trihydroxycoprostanic Acid-d3; 5β-Cholestane-3α,7α,12α-triol-26-oic Acid-d3; Coprocholic Acid-d3; Trihydroxycoprostanic Acid-d3; |
| CAS号: | 338976-79-7 |
| 参考CAS号: | 类似: 547-98-8 |
| 分子式: | C₂₇H₄₃D₃O₅ |
| 外观: | 白色至白色固体 |
| 熔点: | 118 - 121°C |
| 分子量: | 453.67 |
| 储存: | 冰箱 |
| 溶解度: | DMSO (Slightly), Ethanol (Slightly), Methanol (Slightly) |
| 类别: | Standards; Steroids; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites; |
| 应用: | 3α,7α,12α-Trihydroxycoprostanic Acid-d3 is a labelled analogue of 3α,7α,12α-Trihydroxycoprostanic Acid (T795155), a precursor of Cholic Acid (C432600), it undergoes side chain oxidation during the synthesis of bile acids. It was found that Zellweger’s syndrome patients have abnormal mitochondrial structure, the organelle that is responsible for the side chain oxidation, and as a consequence, excess amounts of 3α,7α,12α-Trihydroxycoprostanic Acid. |
| 参考文献 | |
